Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of ornithine phenylacetate (OCR-002) in cirrhotic patients with gastrointestinal hemorrhage
2009-017819-16Phase 2Completed
- Sponsor
- Juan Cordoba
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ornithine phenylacetate in hepatic encephalopathy (HE), Cirrhosis and gastrointestinal bleeding, sponsored by Juan Cordoba. Primary endpoint: Venous ammonia concentration over study duration. Started Dec 2009; status: completed.
02
Drugs
ornithine phenylacetate
03
Conditions
hepatic encephalopathy (HE)Cirrhosisgastrointestinal bleeding
Beyond the preview
Go deeper on 2009-017819-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017819-16.